Wealth Enhancement Advisory Services, LLC Gain Therapeutics, Inc. Put Options Transaction History
Wealth Enhancement Advisory Services, LLC
- $61.1 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GANX
# of Institutions
40Shares Held
4.5MCall Options Held
37.9KPut Options Held
0-
Jones Financial Companies Lllp677KShares$1.12 Million0.0% of portfolio
-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$976,7600.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$939,7750.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA534KShares$887,0240.0% of portfolio
-
Geode Capital Management, LLC Boston, MA290KShares$482,1660.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $19.7M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...